Baseline Oxidative Stress Biomarkers: Why Testing Matters Before Supplementation Before starting glutathione supplementation, understanding your baseline oxidative stress statusvia biomarkers such as malondialdehyde (MDA), 8-isoprostane, or glutathione-to-oxidized-glutathione ratiocan clarify whether supplementation addresses an actual deficit
Excellent Customer Service Our mission and priority are to ensure that clients receive a superior customer experience
enthusiasm dramatically outpaces science FDA Category 2 classifications for peptides like Semax reflect absence of FDA-standard evidence, not documented harmsRussian clinical experience suggests reasonable safety, but long-term effects by Western standards remain uncharacterized Established interventionsexercise, Mediterranean diet, sleep optimization, cardiovascular risk management, cognitive engagementhave far more consistent evidence than any peptide for dementia risk reduction For Research Prioritization Compounds meriting continued investigation: GLP-1 Agonists: Prevention trials in preclinical/presymptomatic populations, testing compounds with better brain penetration (dulaglutide, lixisenatide) SS-31/Elamipretide: Cognitive outcomes in mitochondrial disease populations, potential expansion to brain aging indications P21: Phase I human trials to establish safety, pharmacokinetics, and proof-of-mechanism for CNTF-pathway neurogenesis Klotho: Watch for Phase 1 results from Jocasta Neuroscience (expected 2027-2028)
Its a quick process, but following each step is important for safe and effective results
The Bridge benefit is paid through your Part D plan, whether that is a standalone Prescription Drug Plan (PDP) or a Medicare Advantage plan with prescription drug coverage (MA-PD)
